CLINICAL_TRIALS trial_result · 2021-03-04

Clinical Trial Update: A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1 [Phase 3]

Phase 3 trial update for continued access to TMC278-TIDP6-C222 in HIV-1 infected patients; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Janssen R&D Ireland | Conditions: HIV-1 Infection | Phase 3 | Status: COMPLETED | Results posted: 2021-03-04